Home › Graft-Versus-Host Disease › Massachusetts › Boston
Graft-Versus-Host Disease clinical trials in Boston, MA
10 studies for Graft-Versus-Host Disease are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
Recruiting
- Massachusetts General Hospital, Boston
Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD
RecruitingPhase 1
- Dana-Farber Cancer Institute, Boston
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
RecruitingPhase 2
- Massachusetts General Hospital, Boston
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
RecruitingPhase 3
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis
RecruitingPhase 2
- Boston Children's Hospital, Boston
Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial
Recruiting
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
RecruitingPhase 2
- Dana-Farber Cancer Institute, Boston
Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
RecruitingObservational study
- Dana Farber, Boston
IS-free Treg HaploHCT
RecruitingPhase 1
- Dana Farber Cancer Institute, Boston
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
RecruitingPhase 1
- Dana-Farber Cancer Institute, Boston
Graft-Versus-Host Disease trials in other cities
- New York City, NY7 studies
- Columbus, OH6 studies
- Atlanta, GA5 studies
- Washington, DC5 studies
- St. Louis, MO4 studies
- Portland, OR4 studies
- Baldwin Park, CA4 studies
- Tampa, FL4 studies
- Detroit, MI4 studies
- Pittsburgh, PA4 studies
- Miami, FL4 studies
- Queens, NY4 studies
Other studies in Boston
- Breast Cancer111 studies
- Non-Small Cell Lung Cancer90 studies
- Cancer (all types)86 studies
- Colorectal Cancer63 studies
- Metastatic Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer59 studies
- Depression52 studies
- Endometrial Cancer50 studies
- Heart Failure44 studies
- Acute Myeloid Leukemia44 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.